Key facts
- PeptiSystems’s last known valuation is $16.1M (Dec 2024).
- It has raised $7.2M; the latest was PE Growth/Expansion in Nov 2025.
- Notable investors include Almi Invest, Jinderman & Partners, Nolsterby Invest, Anders Hedlund, Mats Johnsson — 11 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 11 names
- ·Watchlist + deal alerts for PeptiSystems
- ·The full record, as it builds
Funding rounds
No funding rounds for PeptiSystems are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About PeptiSystems
Manufacturer of medical instruments designed for the production of peptides. The company's products include the production of peptides for producing certain types of bioactive molecules for drugs, enabling doctors to help with the treatment of diseases such as AIDS or HIV and diabetes.
- Sector
- Healthcare
- HQ
- Uppsala, Sweden
- Founded
- 2014
- Employees
- 10
- Website
- peptisystems.com/
- Ownership
- Privately Held (backing)
PeptiSystems doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in PeptiSystems shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on PeptiSystems in its N-PORT filings yet. We sweep new filings monthly.